{ "cik": 1048477, "cik_padded": "0001048477", "entityName": "BIOMARIN PHARMACEUTICAL INC", "fiscal_years": [ { "accn": "0001048477-26-000004", "filed": "2026-02-26", "fiscal_year": 2025, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 103038000.0, "cash": 1311679000.0, "eps_diluted": 1.8, "free_cash_flow": 724956000.0, "net_income": 348901000.0, "operating_cash_flow": 827994000.0, "operating_income": 409478000.0, "revenue": 3221253000.0, "stockholders_equity": 6086999000.0, "total_assets": 7594022000.0, "total_liabilities": 1507023000.0 }, "period_end": "2025-12-31", "ratio_units": { "leverage": "ratio", "net_margin": "ratio", "operating_margin": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.24758062224094335, "net_margin": 0.10831220025251044, "operating_margin": 0.12711761541238767, "revenue_growth_yoy": 0.12871371431875162, "roa_avg2y": 0.047850498410405236, "roa_period_end": 0.045944165028755514, "roe_avg2y": 0.059412741893585426, "roe_period_end": 0.0573190499949154 } }, { "accn": "0001048477-26-000004", "filed": "2026-02-26", "fiscal_year": 2024, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 85424000.0, "cash": 942842000.0, "eps_diluted": 2.21, "free_cash_flow": 487417000.0, "net_income": 426859000.0, "operating_cash_flow": 572841000.0, "operating_income": 484214000.0, "revenue": 2853915000.0, "stockholders_equity": 5657990000.0, "total_assets": 6988940000.0, "total_liabilities": 1330950000.0 }, "period_end": "2024-12-31", "ratio_units": { "leverage": "ratio", "net_margin": "ratio", "operating_margin": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.23523371373933147, "net_margin": 0.14956962628529583, "operating_margin": 0.16966658081968103, "revenue_growth_yoy": 0.17968102194668872, "roa_avg2y": 0.06172700522314995, "roa_period_end": 0.06107635778816244, "roe_avg2y": 0.08046702123438162, "roe_period_end": 0.07544357625234403 } }, { "accn": "0001048477-26-000004", "filed": "2026-02-26", "fiscal_year": 2023, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 96691000.0, "cash": 755127000.0, "eps_diluted": 0.87, "free_cash_flow": 62568000.0, "net_income": 167645000.0, "operating_cash_flow": 159259000.0, "operating_income": 185774000.0, "revenue": 2419226000.0, "stockholders_equity": 4951549000.0, "total_assets": 6841603000.0, "total_liabilities": 1890054000.0 }, "period_end": "2023-12-31", "ratio_units": { "leverage": "ratio", "net_margin": "ratio", "operating_margin": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.3817096427804713, "net_margin": 0.06929695696061468, "operating_margin": 0.07679067602613397, "revenue_growth_yoy": 0.15418940201017253, "roa_avg2y": 0.025368706521313945, "roa_period_end": 0.02450376030295824, "roe_avg2y": 0.03509161193359711, "roe_period_end": 0.03385708189497872 } }, { "accn": "0001048477-26-000004", "filed": "2026-02-26", "fiscal_year": 2022, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 120959000.0, "cash": 724531000.0, "eps_diluted": 0.75, "free_cash_flow": 54943000.0, "net_income": 141561000.0, "operating_cash_flow": 175902000.0, "operating_income": 160974000.0, "revenue": 2096039000.0, "stockholders_equity": 4603156000.0, "total_assets": 6375074000.0, "total_liabilities": 1771918000.0 }, "period_end": "2022-12-31", "ratio_units": { "leverage": "ratio", "net_margin": "ratio", "operating_margin": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.38493546601505574, "net_margin": 0.06753738837874677, "operating_margin": 0.07679914352738666, "revenue_growth_yoy": 0.13527995558624797, "roa_avg2y": 0.022869589815576057, "roa_period_end": 0.02220538930214771, "roe_avg2y": 0.03192328183271177, "roe_period_end": 0.03075303118121567 } }, { "accn": "0001048477-25-000007", "filed": "2025-02-24", "fiscal_year": 2021, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 95578000.0, "cash": 587276000.0, "eps_diluted": -0.35, "free_cash_flow": 208958000.0, "net_income": -64080000.0, "operating_cash_flow": 304536000.0, "operating_income": -82341000.0, "revenue": 1846275000.0, "stockholders_equity": 4265669000.0, "total_assets": 6004772000.0, "total_liabilities": 1739103000.0 }, "period_end": "2021-12-31", "ratio_units": { "leverage": "ratio", "net_margin": "ratio", "operating_margin": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.4076975967896243, "net_margin": -0.034707722305723686, "operating_margin": -0.04459844822683511, "revenue_growth_yoy": -0.007621791443490974, "roa_avg2y": -0.010812642287150571, "roa_period_end": -0.010671512590319832, "roe_avg2y": -0.015318050343030621, "roe_period_end": -0.015022262627503447 } }, { "accn": "0001048477-24-000016", "filed": "2024-02-26", "fiscal_year": 2020, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 114312000.0, "cash": 649158000.0, "eps_diluted": 4.5, "free_cash_flow": -28947000.0, "net_income": 854029000.0, "operating_cash_flow": 85365000.0, "operating_income": -43440000.0, "revenue": 1860455000.0, "stockholders_equity": 4100931000.0, "total_assets": 5848020000.0, "total_liabilities": 1742018000.0 }, "period_end": "2020-12-31", "ratio_units": { "leverage": "ratio", "net_margin": "ratio", "operating_margin": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.42478598152468305, "net_margin": 0.4590430835467668, "operating_margin": -0.023349126960877854, "revenue_growth_yoy": 0.09178556003117283, "roa_avg2y": 0.16208468751218796, "roa_period_end": 0.14603729125413387, "roe_avg2y": 0.23646465776364084, "roe_period_end": 0.20825246754944182 } }, { "accn": "0001048477-23-000009", "filed": "2023-02-27", "fiscal_year": 2019, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 145026000.0, "cash": 437446000.0, "eps_diluted": -0.13, "free_cash_flow": -96764000.0, "net_income": -23848000.0, "operating_cash_flow": 48262000.0, "operating_income": -100457000.0, "revenue": 1704048000.0, "stockholders_equity": 3122381000.0, "total_assets": 4690039000.0, "total_liabilities": 1567658000.0 }, "period_end": "2019-12-31", "ratio_units": { "leverage": "ratio", "net_margin": "ratio", "operating_margin": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.502071335945229, "net_margin": -0.013994910941475827, "operating_margin": -0.05895197787855741, "revenue_growth_yoy": 0.14272685573882185, "roa_avg2y": -0.00523144963780964, "roa_period_end": -0.005084819124105366, "roe_avg2y": -0.007831442710490957, "roe_period_end": -0.007637761054784794 } }, { "accn": "0001048477-22-000012", "filed": "2022-02-25", "fiscal_year": 2018, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 144620000.0, "cash": 493982000.0, "eps_diluted": -0.44, "free_cash_flow": -124412000.0, "net_income": -77211000.0, "operating_cash_flow": 20208000.0, "operating_income": -123524000.0, "revenue": 1491212000.0, "stockholders_equity": 2967940000.0, "total_assets": 4427128000.0, "total_liabilities": 1459188000.0 }, "period_end": "2018-12-31", "ratio_units": { "leverage": "ratio", "net_margin": "ratio", "operating_margin": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.4916501007432765, "net_margin": -0.051777346212342715, "operating_margin": -0.08283463384146587, "revenue_growth_yoy": 0.13517035791986579, "roa_avg2y": -0.01704389491110237, "roa_period_end": -0.01744042638929798, "roe_avg2y": -0.026732320015760126, "roe_period_end": -0.026015013780602034 } }, { "accn": "0001564590-19-005033", "filed": "2021-02-26", "fiscal_year": 2017, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 199219000.0, "cash": 598028000.0, "eps_diluted": -0.67, "free_cash_flow": -207976000.0, "net_income": -117042000.0, "operating_cash_flow": -8757000.0, "operating_income": -14700000.0, "revenue": 1313646000.0, "stockholders_equity": 2808663000.0, "total_assets": 4633125000.0, "total_liabilities": 1824462000.0 }, "period_end": "2017-12-31", "ratio_units": { "leverage": "ratio", "net_margin": "ratio", "operating_margin": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.6495838055330952, "net_margin": -0.08909706267898658, "operating_margin": -0.011190229331189681, "revenue_growth_yoy": 0.17620208191939143, "roa_avg2y": -0.02704042999648254, "roa_period_end": -0.02526199919061109, "roe_avg2y": -0.04198862839371487, "roe_period_end": -0.041671784760222215 } }, { "accn": "0001564590-19-005033", "filed": "2020-02-27", "fiscal_year": 2016, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 148380000.0, "cash": 408330000.0, "eps_diluted": -3.81, "free_cash_flow": -376217000.0, "net_income": -630210000.0, "operating_cash_flow": -227837000.0, "operating_income": -803429000.0, "revenue": 1116854000.0, "stockholders_equity": 2766275000.0, "total_assets": 4023690000.0, "total_liabilities": 1257415000.0 }, "period_end": "2016-12-31", "ratio_units": { "leverage": "ratio", "net_margin": "ratio", "operating_margin": "ratio", "roa_period_end": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.45455169858383565, "net_margin": -0.5642725011505533, "operating_margin": -0.7193679746860377, "roa_period_end": -0.15662488909433878, "roe_period_end": -0.22781899847267537 } } ], "latest_filing": { "accn": "0001048477-26-000004", "filed": "2026-02-26", "form": "10-K" }, "note": "Static grepcent export of verified SEC companyfacts-derived values. Monetary values are raw reported units from grepcent's resolved facts; no scaling and no FX conversion. Capex, dividends, and buybacks are reported as positive outflow magnitudes. ROE/ROA include both period-end basis (site-consistent) and average-of-two-years basis where the prior-year denominator exists.", "schema_version": "1", "sic": "2834", "sic_description": "Pharmaceutical Preparations", "source_urls": { "sec_companyfacts": "https://data.sec.gov/api/xbrl/companyfacts/CIK0001048477.json", "sec_submissions": "https://data.sec.gov/submissions/CIK0001048477.json" }, "ticker": "BMRN" }